Evidence map›Paper›PMID 35302260›Full record

ReviewPhytotherapy research : PTR2022

Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy.

Annamária Bardelčíková, Andrej Miroššay, Jindřich Šoltýs, Ján Mojžiš

Open access · bronzeAbstract readReview
In one paragraph

Review in Phytotherapy research : PTR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Review
  5. Article
  6. Article
  7. Therapeutic Effect and Safety Evaluation of Naringin onInternational journal of molecular sciences · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. The Potential of Ameliorating COVID-19 and Sequelae FromBioinformatics and biology insights · 2023
    Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Annamária BardelčíkováDepartment of Pharmacology, Medical Faculty of University of Pavol Jozef Šafárik in Košice, Košice, Slovak Republic.ORCID https://orcid.org/0000-0003-4594-3363
Andrej MiroššayDepartment of Pharmacology, Medical Faculty of University of Pavol Jozef Šafárik in Košice, Košice, Slovak Republic.
Jindřich ŠoltýsInstitute of Parasitology, Slovak Academy of Science, Košice, Slovak Republic.
Ján MojžišDepartment of Pharmacology, Medical Faculty of University of Pavol Jozef Šafárik in Košice, Košice, Slovak Republic.
Institute of Parasitology of the Slovak Academy of Sciences · SK

Funding

ERDF
6 · The paper itself

Abstract

The high incidence of post-covid symptoms in humans confirms the need for effective treatment. Due to long-term complications across several disciplines, special treatment programs emerge for affected patients, emphasizing multidisciplinary care. For these reasons, we decided to look at current knowledge about possible long-term complications of COVID-19 disease and then present the effect of flavonoids, which could help alleviate or eliminate complications in humans after overcoming the COVID-19 infection. Based on articles published from 2003 to 2021, we summarize the flavonoids-based molecular mechanisms associated with the post-COVID-19 syndrome and simultaneously provide a complex view regarding their prophylactic and therapeutic potential. Review clearly sorts out the outcome of post-COVID-19 syndrome according particular body systems. The conclusion is that flavonoids play an important role in prevention of many diseases. We suggest that flavonoids as critical nutritional supplements, are suitable for the alleviation and shortening of the period associated with the post-COVID-19 syndrome. The most promising flavonoid with noteworthy therapeutic and prophylactic effect appears to be quercetin.

Indexed as

COVID-19COVID-19 Drug TreatmentFlavonoidsHumansPost-Acute COVID-19 SyndromeSARS-CoV-2Flavonoidsantiinflammatoryflavonoidspost-COVID-19 syndromeSARS-CoV-19

Identifiers

PMID35302260
PMCPMC9111001
OpenAlexW4220660838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.